Cited by 469Coagulation, Bradykinin, Polyphosphates, and AngioedemaPineapple and bromelain studiesComplement system in diseases

The DOI matches its Crossref record; 326 of the 326 references it cites were found in a registry or an index.

The Kallikrein-Kinin System: Current and Future Pharmacological Targets

Open access

Moreau, Marie Eve, Garbacki, Nancy, Molinaro, Giuseppe, Brown, Nancy J., Marceau, François, Adam, Albert·2005·Journal of Pharmacological Sciences

DOI 10.1254/jphs.srj05001x

Open this paper in CoChat — free account Open PDF

Abstract

The kallikrein-kinin system is an endogenous metabolic cascade, triggering of which results in the release of vasoactive kinins (bradykinin-related peptides). This complex system includes the precursors of kinins known as kininogens and mainly tissue and plasma kallikreins. The pharmacologically active kinins, which are often considered as either proinflammatory or cardioprotective, are implicated in many physiological and pathological processes. The interest of the various components of this multi-protein system is explained in part by the multiplicity of its pharmacological activities, mediated not only by kinins and their receptors, but also by their precursors and their activators and the metallopeptidases and the antiproteases that limit their activities. The regulation of this system by serpins and the wide distribution of the different constituents add to the complexity of this system, as well as its multiple relationships with other important metabolic pathways such as the renin-angiotensin, coagulation, or complement pathways. The purpose of this review is to summarize the main properties of this kallikrein-kinin system and to address the multiple pharmacological interventions that modulate the functions of this system, restraining its proinflammatory effects or potentiating its cardiovascular properties.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1254/jphs.srj05001x

Cites

326 of 326 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114844 · Cited by 3,767
The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
Fredriksson, R., Lagerström, M. C., Lundin, L.-G., & Schiöth, H. B. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1256 · Cited by 2,941
A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
MEROPS: the peptidase database
Rawlings, N. D., & Barrett, A. J. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.325 · Cited by 2,284
Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J., Arveiler, D., Luc, G., Bard, J., Bara, L., Ricard, S., et al. (1992) · Nature · doi:10.1038/359641a0 · Cited by 1,908
A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction
Køber, L., Torp-Pedersen, C. T., Carlsen, J. E., Bagger, H., Eliasen, P., Lyngborg, K., Videbæk, J., Cole, D. S., Auclert, L., Pauly, N., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512213332503 · Cited by 1,768
Bioregulation of kinins: kallikreins, kininogens, and kininases.
Bhoola, K. D., Figueroa, C. D., & Worthy, K. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00058-4 · Cited by 1,744
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V. K., Dick, L. R., Gavin, J. M., Tang, J., Godbout, K., Parsons, T. F., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,406
Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides
Mentlein, R. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00089-0 · Cited by 1,273
Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease
Mancini, G. B. J., Henry, G. C., Macaya, C., O’Neill, B. J., Pucillo, A. L., Carere, R. G., Wargovich, T. J., Mudra, H. G., Lüscher, T. F., Klibaner, M. I., et al. (1996) · Circulation · doi:10.1161/01.cir.94.3.258 · Cited by 1,056
Tranexamic Acid
Dunn, C. J., & Goa, K. L. (1999) · Drugs · doi:10.2165/00003495-199957060-00017 · Cited by 1,020
International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences
Leeb-Lundberg, L. M. F., Marceau, F., Müller‐Esterl, W., Pettibone, D. J., & Zuraw, B. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.2 · Cited by 956
Self-citation
Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV
Lambeir, A.-M., Durinx, C., Scharpé, S., & De Meester, I. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609354 · Cited by 955
Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition
Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H.-J., Hama, E., Sekine-Aizawa, Y., et al. (2000) · Nature Medicine · doi:10.1038/72237 · Cited by 867
Hoe 140 a new potent and long acting bradykinin‐antagonist:in vivostudies
WIRTH, K. J., Hock, F. J., Albus, U., Linz, W., Alpermann, H. G., Anagnostopoulos, H., Henke, S., Breipohl, G., König, W. Α., Knolle, J., et al. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12249.x · Cited by 830
Families of zinc metalloproteases
Hooper, N. M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01079-x · Cited by 802
Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning.
Soubrier, F., Alhenc‐Gelas, F., Hübert, C., Allegrini, J., John, M., Tregear, G. W., & Corvol, P. L. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9386 · Cited by 750
Association between a Deletion Polymorphism of the Angiotensin-Converting-Enzyme Gene and Left Ventricular Hypertrophy
Schunkert, H., Hense, H., Holmer, S. R., Stender, M., Perz, S., Keil, U., Lorell, B. H., & Riegger, G. A. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302302 · Cited by 731
Plasma bradykinin in angio-oedema
Nussberger, J., Cugno, M., Amstutz, C., Cicardi, M., Pellacani, A., & Agostoni, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09137-x · Cited by 706
Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond
Agostoni, A., Aygören‐Pürsün, E., Binkley, K. E., Blanch, A., Bork, K., Bouillet, L., Bucher, C., Castaldo, A. J., Cicardi, M., Davis, A. E., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.047 · Cited by 646
Comparison of Omapatrilat and Enalapril in Patients With Chronic Heart Failure
Packer, M., Califf, R. M., Konstam, M. A., Krum, H., McMurray, J. J. V., Rouleau, J. L., & Swedberg, K. B. (2002) · Circulation · doi:10.1161/01.cir.0000029801.86489.50 · Cited by 612
Hoe 140 a new potent and long acting bradykinin‐antagonist:in vitrostudies
Hock, F. J., WIRTH, K. J., Albus, U., Linz, W., Gerhards, H. J., Wiemer, G., Henke, S., Breipohl, G., König, W. Α., Knolle, J., et al. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12248.x · Cited by 612
Hereditary and Acquired C1-Inhibitor Deficiency
Agostoni, A., & Cicardi, M. (1992) · Medicine · doi:10.1097/00005792-199207000-00003 · Cited by 604
The B1 Receptors for Kinins
Marceau, F., Hess, J. F., & Bachvarov, D. R. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01371-1 · Cited by 604
Self-citation
Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial
Kostis, J. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.09.014 · Cited by 579
Kinin receptors in pain and inflammation
Couture, R., Harrisson, M., Vianna, R. M. J., & Cloutier, F. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01318-8 · Cited by 472
Competitive antagonists of bradykinin
Vavrek, R. J., & Stewart, J. M. (1985) · Peptides · doi:10.1016/0196-9781(85)90033-6 · Cited by 464
The purification and specificity of a neutral endopeptidase from rabbit kidney brush border
Kerr, M. A., & Kenny, A. J. (1974) · Biochemical Journal · doi:10.1042/bj1370477 · Cited by 460
Expression cloning of a human B1 bradykinin receptor.
Menke, J. G., Borkowski, J. A., Bierilo, K. K., MacNeil, T., Derrick, A., Schneck, K., Ransom, R. W., Strader, C. D., Linemeyer, D. L., & Hess, J. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31844-6 · Cited by 459
Effect of Bradykinin-Receptor Blockade on the Response to Angiotensin-Converting–Enzyme Inhibitor in Normotensive and Hypertensive Subjects
Gainer, J. V., Morrow, J. D., Loveland, A., King, D. J., & Brown, N. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810293391804 · Cited by 442
Self-citation
Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene
Hübert, C., Houot, A.-M., Corvol, P. L., & Soubrier, F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98626-6 · Cited by 424
Expression cloning of a rat B2 bradykinin receptor.
McEachern, A. E., Shelton, E. R., Bhakta, S., Obernolte, R., Bach, C., Zuppan, P., Fujisaki, J., Aldrich, R. W., & Jarnagin, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7724 · Cited by 421
Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells.
Emeis, J. J., & Kooistra, T. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.163.5.1260 · Cited by 410
The angiotensin–converting enzyme gene family: genomics and pharmacology
Turner, A. J., & Hooper, N. M. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01994-5 · Cited by 407
Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX
Turner, A. J., & Tanzawa, K. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.5.9141502 · Cited by 400
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial
Rouleau, J. L., Pfeffer, M. A., Stewart, D. J., Isaac, D., Sestier, F., Kerut, E. K., Porter, C., Proulx, G., Qian, C., & Block, A. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02602-7 · Cited by 391
Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors
Pesquero, J. B., Araújo, R. C., Heppenstall, P. A., Stucky, C. L., Silva, J. A., Walther, T., de Oliveira, S. M., Pesquero, J. L., Paiva, A. C. M., Calixto, J. Β., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120035997 · Cited by 376
Increased vascular permeability in C1 inhibitor–deficient mice mediated by the bradykinin type 2 receptor
Han, E. D., MacFarlane, R. C., Mulligan, A. N., Scafidi, J., & Davis, A. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14211 · Cited by 363
Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.
Mandle, R. J., Colman, R. W., & Kaplan, A. P. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.11.4179 · Cited by 349
Angiotensin-converting enzyme and male fertility
Hagaman, J. R., Moyer, J. S., Bachman, E. S., Sibony, M., Magyar, P. L., Welch, J. E., Smithies, O., Krege, J. H., & O’Brien, D. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2552 · Cited by 339
Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.
Marre, M., Jeunemaı̂tre, X., Gallois, Y., Rodier, M., Châtellier, G., Sert, C., Dusselier, L., Kahal, Z., Chaillous, L., Halimi, S., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119321 · Cited by 320
Pathways for bradykinin formation and inflammatory disease
Kaplan, A. P., Joseph, K., & Silverberg, M. B. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.121316 · Cited by 303
Increased vascular permeability in C1 inhibitor–deficient mice mediated by the bradykinin type 2 receptor
Han, E. D., MacFarlane, R. C., Mulligan, A. N., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214211 · Cited by 299
Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme.
Ehlers, M. R., Fox, E. A., Strydom, D. J., & Riordan, J. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.7741 · Cited by 293
Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides
Gafford, J. T., Skidgel, R. A., Erdös, E. G., & Hersh, L. B. (1983) · Biochemistry · doi:10.1021/bi00282a035 · Cited by 286
Reply to: 'Clearance of amyloid β-peptide from brain: transport or metabolism?'
Iwata, N., Tsubuki, S., Hama, E., Takaki, Y., Shirotani, K., & Saido, T. C. (2000) · Nature Medicine · doi:10.1038/77399 · Cited by 285
The coagulation-kinin pathway of human plasma
Kaplan, A. P., & Silverberg, M. (1987) · Blood · doi:10.1182/blood.v70.1.1.bloodjournal7011 · Cited by 277
Receptors for bradykinin in rabbit aortae
Regoli, D. C., Barabé, J., & Park, W. K. (1977) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y77-115 · Cited by 260
Bradykinin Sequesters B2 Bradykinin Receptors and the Receptor-coupled Gα Subunits Gαq and Gαiin Caveolae in DDT1 MF-2 Smooth Muscle Cells
WEERD, W. F. C. D., & Leeb-Lundberg, L. M. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17858 · Cited by 258
Bradykinin receptors and their antagonists
Regoli, D. C., Allogho, S. N., Rizzi, A., & Gobeil, F. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00165-4 · Cited by 257
Bradykinin-Mediated Angioedema
Nussberger, J., Cugno, M., & Cicardi, M. (2002) · New England Journal of Medicine · doi:10.1056/nejm200208223470820 · Cited by 236
Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).
Joseph, K., Ghebrehiwet, B., Peerschke, E. I. B., Reid, K. B. M., & Kaplan, A. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8552 · Cited by 217
Structural organization of the human kininogen gene and a model for its evolution.
Kitamura, N., Kitagawa, H., Fukushima, D., Takagaki, Y., Miyata, T., & Nakanishi, S. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39516-9 · Cited by 215
Bradykinin and the pathophysiology of angioedema
Cugno, M., Nussberger, J., Cicardi, M., & Agostoni, A. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00162-5 · Cited by 215
Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases
Salvesen, G. S., Parkes, C., Abrahamson, M., GRUBB, A. O., & Barrett, A. J. (1986) · Biochemical Journal · doi:10.1042/bj2340429 · Cited by 212
Angiotensin-converting enzyme is a GPI-anchored protein releasing factor crucial for fertilization
Kondoh, G., Tojo, H., Nakatani, Y., Komazawa, N., Murata, C., Yamagata, K., Maeda, Y., Kinoshita, T., Okabe, M., Taguchi, R., et al. (2005) · Nature Medicine · doi:10.1038/nm1179 · Cited by 211
Tranexamic Acid
Wellington, K., & Wagstaff, A. J. (2003) · Drugs · doi:10.2165/00003495-200363130-00008 · Cited by 210
Isolation and Characterization of the Kininogen-binding Protein p33 from Endothelial Cells
Herwald, H., Dedio, J., Kellner, R., Loos, M., & Müller‐Esterl, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13040 · Cited by 209
The regulation of human factor XIIa by plasma proteinase inhibitors.
Pixley, R. A., Schapira, M., & Colman, R. W. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89653-3 · Cited by 208
Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor.
Colman, R. W., Pixley, R. A., Najamunnisa, S., Yan, W., Wang, J., Mazar, A. P., & McCrae, K. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119669 · Cited by 208
Basic carboxypeptidases: regulators of peptide hormone activity
Skidgel, R. A. (1988) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(88)90015-6 · Cited by 207
Role of Endogenous Bradykinin in Human Coronary Vasomotor Control
Groves, P. H., Kurz, S. K., Just, H., & Drexler, H. (1995) · Circulation · doi:10.1161/01.cir.92.12.3424 · Cited by 205
Induction of B1-receptors for kinins in the rabbit by a bacterial lipopolysaccharide
Regoli, D. C., Marceau, F., & Lavigne, J. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90391-5 · Cited by 204
Self-citation
Treatment of Severe Systemic Inflammatory Response Syndrome and Sepsis With a Novel Bradykinin Antagonist, Deltibant (CP-0127) Results of a Randomized, Double-blind, Placebo-Controlled Trial
Fein, A. M. (1997) · JAMA · doi:10.1001/jama.277.6.482 · Cited by 199
The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts.
Schanstra, J. P., Bataillé, E., Castano, M. E. M., Barascud, Y., Hirtz, C., Pesquero, J. B., Pécher, C., Gauthier, F., Girolami, J., & Bascands, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1359 · Cited by 196
Cloning and sequence analysis of cDNAs for human high molecular weight and low molecular weight prekininogens. Primary structures of two human prekininogens.
Takagaki, Y., Kitamura, N., & Nakanishi, S. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39515-7 · Cited by 184
Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors
Adam, A., Cugno, M., Molinaro, G., Perez, M., Lepage, Y., & Agostoni, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08914-6 · Cited by 181
Self-citation
Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis
Colman, R. W., Jameson, B. A., Lin, Y., Johnson, D., & Mousa, S. A. (2000) · Blood · doi:10.1182/blood.v95.2.543 · Cited by 179
The expression of high molecular weight kininogen on human umbilical vein endothelial cells.
Schmaier, A. H., Kuo, A., Lundberg, D., Murray, S., & Cines, D. B. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37596-3 · Cited by 177
Calcium Signaling in Endothelial Cells Involves Activation of Tyrosine Kinases and Leads to Activation of Mitogen-Activated Protein Kinases
Fleming, I., Fißlthaler, B., & Busse, R. (1995) · Circulation Research · doi:10.1161/01.res.76.4.522 · Cited by 176
A DNA Variant at the Angiotensin-Converting Enzyme Gene Locus Associates With Coronary Artery Disease in the Caerphilly Heart Study
Mattu, R. K., Needham, E. W., Galton, D. J., Frangos, E., Clark, A., & Caulfield, M. J. (1995) · Circulation · doi:10.1161/01.cir.91.2.270 · Cited by 175
High Molecular Weight Kininogen Regulates Prekallikrein Assembly and Activation on Endothelial Cells: A Novel Mechanism for Contact Activation
Motta, G., Røjkjær, R., Hasan, A., Cines, D. B., & Schmaier, A. H. (1998) · Blood · doi:10.1182/blood.v91.2.516.516_516_528 · Cited by 175
Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes
Mahdi, F., Madar, Z. S., Figueroa, C. D., & Schmaier, A. H. (2002) · Blood · doi:10.1182/blood.v99.10.3585 · Cited by 171
Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells
Hasan, A., Zisman, T. L., & Schmaier, A. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3615 · Cited by 163
Anterior pituitary hormones, stress, and immune system homeostasis
Dorshkind, K. A., & Horseman, N. D. (2001) · BioEssays · doi:10.1002/1521-1878(200103)23:3 · Cited by 157
Roles of the Two Active Sites of Somatic Angiotensin-Converting Enzyme in the Cleavage of Angiotensin I and Bradykinin
Georgiadis, D., Beau, F., Czarny, B., Cotton, J., Yiotakis, A., & Dive, V. (2003) · Circulation Research · doi:10.1161/01.res.0000081593.33848.fc · Cited by 157
Effect of High Salt Intake in Mutant Mice Lacking Bradykinin-B 2 Receptors
Alfie, M. E., Sigmon, D. H., Pomposiello, S. I., & Carretero, O. A. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.483 · Cited by 154
The Expanded Human Kallikrein (KLK) Gene Family: Genomic Organisation, Tissue-Specific Expression and Potential Functions
Clements, J. A., Hooper, J. D., Dong, Y., & Harvey, T. J. (2001) · Biological Chemistry · doi:10.1515/bc.2001.002 · Cited by 153
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.
Pahor, M., Psaty, B. M., Alderman, M. H., Applegate, W. B., Williamson, J. D., & Furberg, C. D. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.888 · Cited by 145
Kinins and their receptors in hyperalgesia
Dray, A. (1997) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-75-6-704 · Cited by 144
Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema Is Characterized by a Slower Degradation of des-Arginine9-Bradykinin
Molinaro, G., Cugno, M., Perez, M., Lepage, Y., Gervais, N., Agostoni, A., & Adam, A. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.038067 · Cited by 137
Self-citation
[Kallikreins and kinins].
BULUK, K., Zuch, A., & Czokało, M. (1972) · PubMed · Cited by 137
The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins
Blais, C., Marceau, F., Rouleau, J.-L., & Adam, A. (2000) · Peptides · doi:10.1016/s0196-9781(00)00348-x · Cited by 135
Self-citation
Angiotensin-Converting Enzyme Is Involved in Outside-In Signaling in Endothelial Cells
Kohlstedt, K., Brandes, R. P., Müller‐Esterl, W., Busse, R., & Fleming, I. (2003) · Circulation Research · doi:10.1161/01.res.0000107195.13573.e4 · Cited by 135
Bradykinin receptor gene variant and human physical performance
Williams, A. G., Dhamrait, S. S., Wootton, P. T. E., Day, S. H., Hawe, E., Payne, J. R., Myerson, S. G., WORLD, M. J., Budgett, R., Humphries, S. E., et al. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00865.2003 · Cited by 132
Ligand-induced Phosphorylation/Dephosphorylation of the Endogenous Bradykinin B2 Receptor from Human Fibroblasts
Blaukat, A., AbdAlla, S., Lohse, M. J., & Müller‐Esterl, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.32366 · Cited by 129
MEROPS: the peptidase database
Rawlings, N. D. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.323 · Cited by 129
Some Old and Some New Ideas on Kinin Metabolism
Erdös, E. G. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199000156-00005 · Cited by 128
Autoregulation of Bradykinin Receptors: Agonists in the Presence of Interleukin-1β Shift the Repertoire of Receptor Subtypes from B2 to B1 in Human Lung Fibroblasts
Phagoo, S. B., Poole, S., & Leeb-Lundberg, L. M. F. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.2.325 · Cited by 128
Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI.
Tait, J. F., & Fujikawa, K. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60859-2 · Cited by 126
SSR240612 [(2 R)-2-[((3 R)-3-(1,3-Benzodioxol-5-yl)-3-{[(6-methoxy-2-naphthyl)sulfonyl]amino}propanoyl)amino]-3-(4-{[2 R,6 S)-2,6-dimethylpiperidinyl]methyl}phenyl)-N-isopropyl-N-methylpropanamide Hydrochloride], a New Nonpeptide Antagonist of the Bradykinin B1 Receptor: Biochemical and Pharmacological Characterization
Gougat, J., Ferrari, B., Sarran, L., Planchenault, C., Poncelet, M., Maruani, J., Alonso, R., Cudennec, A., Croci, T., Guagnini, F., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.059527 · Cited by 124
Bradykinin Contributes to the Vasodilator Effects of Chronic Angiotensin-Converting Enzyme Inhibition in Patients With Heart Failure
Witherow, F. N., Helmy, A., Webb, D. J., Fox, K. A. A., & Newby, D. E. (2001) · Circulation · doi:10.1161/hc4301.098252 · Cited by 124
Targeting Kinin B 1 Receptor for Therapeutic Neovascularization
Emanueli, C., Salis, M. B., Stacca, T., Pintus, G., Kirchmair, R., Isner, J. M., Pinna, A., Gaspa, L., Regoli, D. C., Cayla, C., et al. (2002) · Circulation · doi:10.1161/hc0302.102142 · Cited by 123
Mapping the Cell Binding Site on High Molecular Weight Kininogen Domain 5
Hasan, A., Cines, D. B., Herwald, H., Schmaier, A. H., & Müller‐Esterl, W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.33.19256 · Cited by 121
Bradykinin B1 receptor is constitutively expressed in the rat sensory nervous system
Wotherspoon, G., & Winter, J. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01561-5 · Cited by 117
Bradykinin B2BKR receptor polymorphism and left-ventricular growth response
Brull, D. J., Dhamrait, S. S., Myerson, S. G., Erdmann, J., Regitz‐Zagrosek, V., World, M., Pennell, D. J., Humphries, S. E., & Montgomery, H. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06273-0 · Cited by 117
Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke.
Hill, M. D., Barber, P. A., Takahashi, J., Demchuk, A. M., Feasby, T. E., & Buchan, A. M. (2000) · Europe PMC (PubMed Central) · Cited by 117
ACE Insertion/Deletion Genotype Affects Bradykinin Metabolism
Brown, N. J., Blais, C., Gandhi, S., & Adam, A. A. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199809000-00006 · Cited by 116
Self-citation
Molecular Cloning and Sequencing of the cDNA for Human Membrane-bound Carboxypeptidase M
Tan, F., Chan, S. J., Steiner, D. F., Schilling, J., & Skidgel, R. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51610-0 · Cited by 115
Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain
Levy, D., & Zochodne, D. W. (2000) · Pain · doi:10.1016/s0304-3959(00)00256-6 · Cited by 115
Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N‐terminal cytokine sequences
Hoffmann, T., Faust, J., Neubert, K., & ANSORGE, S. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81609-4 · Cited by 115
Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP
Ignarro, L. J., Byrns, R. E., Buga, G. M., & Wood, K. S. (1987) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1987.253.5.h1074 · Cited by 115
Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis
VERRESEN, L., Waer, M., Vanrenterghem, Y. F. C., & Michielsen, P. P. (1990) · The Lancet · doi:10.1016/0140-6736(90)92904-v · Cited by 114
Kinins and their receptors in hyperalgesia
Dray, A. (1997) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y97-068 · Cited by 114
Ectoenzymes of the kidney microvillar membrane Aminopeptidase P is anchored by a glycosyl‐phosphatidylinositol moiety
Hooper, N. M., & Turner, A. J. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)81152-9 · Cited by 113
Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema
Lefebvre, J., Murphey, L. J., Hartert, T. V., Jiao Shan, R., Simmons, W. H., & Brown, N. J. (2002) · Hypertension · doi:10.1161/hy0202.103054 · Cited by 113
Self-citation
The Development of the Bradykinin Agonist Labradimil as a Means to Increase the Permeability of the Blood-Brain Barrier
Emerich, D. F., Dean, R. L., Osborn, C., & Bartus, R. T. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140020-00003 · Cited by 112
First Total Synthesis of Martinellic Acid, a Naturally Occurring Bradykinin Receptor Antagonist
Ma, D., Xia, C., Jiang, J., & Zhang, J. (2001) · Organic Letters · doi:10.1021/ol016043h · Cited by 111
Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells
Mahdi, F., Shariat‐Madar, Z., Todd, R. F., Figueroa, C. D., & Schmaier, A. H. (2001) · Blood · doi:10.1182/blood.v97.8.2342 · Cited by 110
Bradykinin‐induced activation of nociceptors: receptor and mechanistic studies on the neonatal rat spinal cord‐tail preparation in vitro
Dray, A., Patel, I. A., Perkins, M., & Rueff, A. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb13418.x · Cited by 110
Identification of an endothelial cell binding site on kininogen domain D3
Herwald, H., Hasan, A., Godovac‐Zimmermann, J., Schmaier, A. H., & Müller‐Esterl, W. (1995) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92103-4 · Cited by 109
Characterization of a secretase activity which releases angiotensin-converting enzyme from the membrane
Oppong, S. Y., & Hooper, N. M. (1993) · Biochemical Journal · doi:10.1042/bj2920597 · Cited by 109
The clinical, cardiac, renal, arterial and neurohormonal effects of omapatrilat, a vasopeptidase inhibitor, in patients with chronic heart failure
McClean, D. R., Ikram, H., Garlick, A. H., Richards, M., Nicholls, M. G., & Crozier, I. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00741-5 · Cited by 109
The binding of high molecular weight kininogen to cultured human endothelial cells.
van Iwaarden, F., de Groot, P. G., & Bouma, B. N. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68839-8 · Cited by 108
Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert® P) in hereditary angioedema: a review
Serres, J. D., Gröner, A., & Lindner, J. K. (2003) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2003.08.006 · Cited by 108
Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: influence of enalaprilat
Décarie, A., Raymond, P., Gervais, N., Couture, R., & Adam, A. A. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.271.4.h1340 · Cited by 107
Self-citation
Bradyzide, a potent non‐peptide B2 bradykinin receptor antagonist with long‐lasting oral activity in animal models of inflammatory hyperalgesia
Burgess, G. M., Perkins, M., Rang, H. P., Campbell, E. A., Brown, M. C., McIntyre, P., Urbán, L., Dziadulewicz, E. K., Ritchie, T. J., Hallett, A., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703012 · Cited by 105
Endothelial nitric oxide synthase interactions with G-protein-coupled receptors
Marrero, M. B., Venema, V. J., Ju, H., He, H., Liang, H., Caldwell, R. B., & Venema, R. C. (1999) · Biochemical Journal · doi:10.1042/bj3430335 · Cited by 105
Bradykinin activates the Janus-activated kinase/signal transducers and activators of transcription (JAK/STAT) pathway in vascular endothelial cells: localization of JAK/STAT signalling proteins in plasmalemmal caveolae
Ju, H., Venema, V. J., Liang, H., Harris, M. B., Zou, R., & Venema, R. C. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510257 · Cited by 104
Bradykinin B2Receptor Gene Polymorphism Is Associated With Angiotensin-Converting Enzyme Inhibitor–Related Cough
Mukae, S., Aoki, S., Itoh, S., Iwata, T., Ueda, H., & Katagiri, T. (2000) · Hypertension · doi:10.1161/01.hyp.36.1.127 · Cited by 103
Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells
Velarde, V., Ullian, M. E., Morinelli, T. A., Mayfield, R. K., & Jaffa, A. A. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.2.c253 · Cited by 103
Agonist-Induced Translocation of the Kinin B1 Receptor to Caveolae-Related Rafts
Sabourin, T., Bastien, L., Bachvarov, D. R., & Marceau, F. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.3.546 · Cited by 102
Self-citation
Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung.
Prechel, M. M., Orawski, A. T., Maggiora, L. L., & Simmons, W. H. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12164-2 · Cited by 102
Blood coagulation
Norris, L. (2003) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/s1521-6934(03)00014-2 · Cited by 101
Role of the Mitogen-Activated Protein Kinases in the Expression of the Kinin B1 Receptors Induced by Tissue Injury
Larrivée, J., Bachvarov, D. R., Houle, F., Landry, J., Huot, J., & Marceau, F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1419 · Cited by 100
Self-citation
Vasopeptidase Inhibition with Omapatrilat Improves Cardiac Geometry and Survival in Cardiomyopathic Hamsters More Than Does ACE Inhibition with Captopril
Trippodo, N. C., Fox, M., Monticello, T. M., Panchal, B. C., & Asaad, M. M. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199912000-00003 · Cited by 100
Membrane-bound aminopeptidase P from bovine lung. Its purification, properties, and degradation of bradykinin.
Simmons, W. H., & Orawski, A. T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42915-8 · Cited by 97
Metabolism of vasoactive peptides by plasma and purified renal aminopeptidase M
Ward, P. E., Benter, I. F., Dick, L. B., & Wilk, S. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90348-o · Cited by 97
Angiotensin-Converting Enzyme Inhibition Increases Human Vascular Tissue-Type Plasminogen Activator Release Through Endogenous Bradykinin
Pretorius, M., Rosenbaum, D., Vaughan, D. E., & Brown, N. J. (2003) · Circulation · doi:10.1161/01.cir.0000046268.59922.a4 · Cited by 96
Self-citation
Design of potent non-peptide competitive antagonists of the human bradykinin B2 receptor
Salvino, J. M., Seoane, P. R., Douty, B. D., Awad, M. M. A., Dolle, R. E., Houck, W. T., Faunce, D. M., & Sawutz, D. G. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00069a021 · Cited by 96
Biochemical Basis of Angioedema Associated With Recombinant Tissue Plasminogen Activator Treatment
Molinaro, G., Gervais, N., & Adam, A. A. (2002) · Stroke · doi:10.1161/01.str.0000017284.77838.87 · Cited by 96
Self-citation
Aminopeptidase P from rat brain
HARBECK, H., & Mentlein, R. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16035.x · Cited by 95
ACE1 polymorphism and progression of SARS
Itoyama, S., Keicho, N., Quy, T., Phi, N. C., Long, H. T., Hà, L. D., Ban, V. V., Ohashi, J., Hijikata, M., Matsushita, I., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.208 · Cited by 95
Renin–angiotensin system gene polymorphisms: potential mechanisms for their association with cardiovascular diseases
Danser, A. H. J., & Schunkert, H. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00823-2 · Cited by 95
The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor protein
Allinson, T. M. J., Parkin, E. T., Condon, T. P., Schwager, S. L. U., Sturrock, E. D., Turner, A. J., & Hooper, N. M. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04184.x · Cited by 94
Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation
Zhao, Y., Qiu, Q., Mahdi, F., Shariat‐Madar, Z., Røjkjær, R., & Schmaier, A. H. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.4.h1821 · Cited by 93
In vivo B1 kinin‐receptor upregulation. Evidence for involvement of protein kinases and nuclear factor κB pathways
Campos, M. M., de Souza, G. E. P., & Calixto, J. Β. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702715 · Cited by 92
Influence of the Cytosolic Carboxyl Termini of Human B1 and B2 Kinin Receptors on Receptor Sequestration, Ligand Internalization, and Signal Transduction
Faußner, A., Proud, D., Towns, M. C., & Bathon, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2617 · Cited by 92
Cloning, Expression, and Characterization of Human Cytosolic Aminopeptidase P: A Single Manganese(II)-Dependent Enzyme
Cottrell, G. S., Hooper, N. M., & Turner, A. J. (2000) · Biochemistry · doi:10.1021/bi001585c · Cited by 91
Efficacy and tolerability of Icatibant (Hoe 140) in patients with moderately severe chronic bronchial asthma
Akbary, A., WIRTH, K. J., & Schölkens, B. A. (1996) · Immunopharmacology · doi:10.1016/0162-3109(96)00065-3 · Cited by 91
Induction of Bl receptors In vivo in a model of persistent inflammatory mechanical hyperalgesia in the rat
Aj, D., & Perkins, M. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90107-4 · Cited by 89
Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: A rationale for prophylactic use of tranexamic acid
Cugno, M., Cicardi, M., & Agostoni, A. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(94)90380-8 · Cited by 89
Generation of plasmin during acute attacks of hereditary angioedema.
Cugno, M., Hack, C. E., de Boer, J. P., Eerenberg, A. J. M., Agostoni, A., & Cicardi, M. (1993) · PubMed · Cited by 86
Post-translational mechanisms of endothelial nitric oxide synthase regulation by bradykinin
Venema, R. C. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00185-6 · Cited by 85
Molecular biology of the angiotensin I converting enzyme: I. Biochemistry and structure of the gene
Soubrier, F., Hübert, C., Testut, P., Nadaud, S., Alhenc‐Gelas, F., & Corvol, P. L. (1993) · Journal of Hypertension · doi:10.1097/00004872-199305000-00001 · Cited by 84
Antagonists of bradykinin that stabilize a G-protein-uncoupled state of the B2 receptor act as inverse agonists in rat myometrial cells
Leeb-Lundberg, L. M. F., Mathis, S. A., & Herzig, M. C. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47145-1 · Cited by 83
Divining the serpin inhibition mechanism: a suicide substrate ‘springe’?
Engh, R. A., Huber, R., Bode, W., & Schulze, A. (1995) · Trends in biotechnology · doi:10.1016/s0167-7799(00)89013-7 · Cited by 83
The Fibrinolysis System: Regulation of Activity and Physiologic Functions of Its Main Components
Борисович, Д. А., & Владимировна, Т. Е. (2002) · Biochemistry (Moscow) · doi:10.1023/a:1013960416302 · Cited by 83
CK2 Phosphorylates the Angiotensin-Converting Enzyme and Regulates Its Retention in the Endothelial Cell Plasma Membrane
Kohlstedt, K., Shoghi, F., Müller‐Esterl, W., Busse, R., & Fleming, I. (2002) · Circulation Research · doi:10.1161/01.res.0000038114.17939.c8 · Cited by 81
Interdependence of Calcium Signaling and Protein Tyrosine Phosphorylation in Human Endothelial Cells
Fleming, I., Fißlthaler, B., & Busse, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.11009 · Cited by 80
The role of bradykinin B1 receptors in the maintenance of intra‐articular plasma extravasation in chronic antigen‐induced arthritis
Cruwys, S., Garrett, N. E., Perkins, M., Blake, D. R., & Kidd, B. L. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17083.x · Cited by 80
Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus
Couture, R., & Girolami, J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.045 · Cited by 79
Domain 3 of kininogens contains a cell-binding site and a site that modifies thrombin activation of platelets.
Jiang, Y., Müller‐Esterl, W., & Schmaier, A. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50583-x · Cited by 78
Bradykinin metabolism and hypotensive transfusion reactions
Cyr, M., Eastlund, T., Blais, C., Rouleau, J. L., & Adam, A. A. (2001) · Transfusion · doi:10.1046/j.1537-2995.2001.41010136.x · Cited by 78
Self-citation
The Intrinsic Coagulation/Kinin-Forming Cascade: Assembly in Plasma and Cell Surfaces in Inflammation
Kaplan, A. P., Joseph, K., Shibayama, Y., Reddigari, S. R., Ghebrehiwet, B., & Silverberg, M. B. (1997) · Advances in immunology · doi:10.1016/s0065-2776(08)60599-4 · Cited by 77
The Human Bradykinin B2 Receptor Gene: Full-Length cDNA, Genomic Organization and Identification of the Regulatory Region
Kammerer, S., Braun, A. D., Arnold, N., & Roscher, A. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1800 · Cited by 75
Gene structure and chromosomal localization of plasma kallikrein
Beaubien, G., Rosinski‐Chupin, I., Mattéi, M., Mbikay, M., Chrétien, M., & Seidah, N. G. (1991) · Biochemistry · doi:10.1021/bi00220a027 · Cited by 75
Up-Regulation of Functional Kinin B1 Receptors in Allergic Airway Inflammation
Christiansen, S. C., Eddleston, J., Woessner, K. M., Chambers, S. S., Ye, R. D., Pan, Z. K., & Zuraw, B. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.2054 · Cited by 74
Staphylococcus aureus Induces Release of Bradykinin in Human Plasma
Mattsson, E., Herwald, H., Cramer, H., Persson, K., Sjöbring, U., & Björck, L. (2001) · Infection and Immunity · doi:10.1128/iai.69.6.3877-3882.2001 · Cited by 74
Kinin B1Receptor Expression and Function on Human Brain Endothelial Cells
Prat, A., Biernacki, K., Pouly, S., Nalbantoglu, J. N., Couture, R., & Antel, J. P. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.10.896 · Cited by 74
Beneficial effect of chronic treatment with the selective bradykinin B1 receptor antagonists, R-715 and R-954, in attenuating streptozotocin-diabetic thermal hyperalgesia in mice
Gabra, B. H., & Sirois, P. (2003) · Peptides · doi:10.1016/j.peptides.2003.06.003 · Cited by 73
Substrate Specificity of Aminopeptidase P from Escherichia coli: Comparison with Membrane-Bound Forms from Rat and Bovine Lung
Yoshimoto, T., Orawski, A. T., & Simmons, W. H. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1204 · Cited by 73
Novel Subtype-Selective Nonpeptide Bradykinin Receptor Antagonists FR167344 and FR173657
Aramori, I., Zenkoh, J., Morikawa, N., O’Donnell, N., Asano, M., Nakamura, K., Iwami, M., Kojo, H., & Notsu, Y. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.2.171 · Cited by 73
The mechanism by which the light chain of cleaved hmw-kininogen augments the activation of prekallikrein, factor XI and hageman factor
Silverberg, M. B., Nicoll, J. E., & Kaplan, A. P. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90383-7 · Cited by 72
Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with Danazol
Pappalardo, E. M., Zingale, L. C., & Cicardi, M. (2003) · Immunology Letters · doi:10.1016/s0165-2478(03)00029-4 · Cited by 70
Molecular Responses of Endothelial Tissue to Kinins
Busse, R., & Fleming, I. (1996) · Diabetes · doi:10.2337/diab.45.1.s8 · Cited by 70
Clinical Trials Update: Highlights of the Scientific Sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL
Coletta, A. P., Thackray, S. D. R., Nikitin, N. P., & Cleland, J. G. F. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00040-5 · Cited by 69
ACE I/D polymorphism is a risk factor of Alzheimer's disease but not of vascular dementia
Kölsch, H., Jessen, F., Freymann, N., Kreis, M., Hentschel, F., Maier, W., & Heun, R. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.062 · Cited by 69
Properties and Distribution of Angiotensin I Converting Enzyme
Igic, R. P., & Behnia, R. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033455459 · Cited by 69
Structure and Genomic Organization of the Human B1Receptor Gene for Kinins (BDKRB1)
Bachvarov, D. R., Hess, J. F., Menke, J. G., Larrivée, J., & Marceau, F. (1996) · Genomics · doi:10.1006/geno.1996.0213 · Cited by 69
Self-citation
Metabolism of Bradykinin by Peptidases in Health and Disease
Erdös, E. G., & Skidgel, R. A. (1997) · Elsevier eBooks · doi:10.1016/b978-012249340-9/50009-7 · Cited by 68
Bradykinin B 1 Receptor Expression Induced by Tissue Damage in the Rat Portal Vein
Medeiros, R., Cabrini, D. A., Ferreira, J., Fernandes, E. S., Mori, M. A., Pesquero, J. B., Bäder, M., Avellar, M. C. W., Campos, M. M., & Calixto, J. Β. (2004) · Circulation Research · doi:10.1161/01.res.0000128404.65887.08 · Cited by 68
Novel Roles of Kallistatin, a Specific Tissue Kallikrein Inhibitor, in Vascular Remodeling
Chao, J., Miao, R. Q., Chen, V. C., Chen, L., & Chao, L. (2001) · Biological Chemistry · doi:10.1515/bc.2001.003 · Cited by 66
Role of kinins in seasonal allergic rhinitis: Icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen
Turner, P., Dear, J. W., Scadding, G. K., & Foreman, J. C. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.111145 · Cited by 66
Upregulation of bradykinin B1‐receptor expression after myocardial infarction
Tschöpe, C., Heringer‐Walther, S., Koch, M., Spillmann, F., Wendorf, M., Leitner, E., Schultheiss, H., & Walther, T. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703239 · Cited by 65
Roles for interleukin-1β, phorbol ester and a post-transcriptional regulator in the control of bradykinin B1 receptor gene expression
Zhou, X. C., POLGAR, P. R., & Taylor, L. (1998) · Biochemical Journal · doi:10.1042/bj3300361 · Cited by 65
A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme
Andújar‐Sánchez, M., Cámara-Artigas, A., & Jara‐Pérez, V. (2004) · Biophysical Chemistry · doi:10.1016/j.bpc.2004.05.011 · Cited by 64
Kallikrein and kinin receptor genes
Mahabeer, R. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00080-2 · Cited by 63
Fibrinolytic properties of activated FXII
Schenk‐Braat, E. A. M., Dooijewaard, G., & Rijken, D. C. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00593.x · Cited by 63
Vasopeptidase Inhibitor Omapatrilat Induces Profound Insulin Sensitization and Increases Myocardial Glucose Uptake in Zucker Fatty Rats
Wang, C., Leung, N. M., Lapointe, N., Szeto, L., Uffelman, K. D., Giacca, A., Rouleau, J. L., & Lewis, G. F. (2003) · Circulation · doi:10.1161/01.cir.0000062646.09566.cc · Cited by 62
Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension
Dhamrait, S. S. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00441-x · Cited by 62
Inhibition by converting enzyme inhibitors of pig kidney aminopeptidase P.
Hooper, N. M., Hryszko, J., Oppong, S. Y., & Turner, A. J. (1992) · Hypertension · doi:10.1161/01.hyp.19.3.281 · Cited by 62
Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains
Reddigari, S., Kuna, P., Miragliotta, G., Shibayama, Y., Nishikawa, K., & Kaplan, A. P. (1993) · Blood · doi:10.1182/blood.v81.5.1306.1306 · Cited by 62
Role of heat shock protein 90 in bradykinin-stimulated endothelial nitric oxide release
Harris, M. B., Ju, H., Venema, V. J., Blackstone, M. A., & Venema, R. C. (2000) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(01)00104-5 · Cited by 61
How do we treat patients with hereditary angioedema
Cicardi, M., & Zingale, L. C. (2003) · Transfusion and Apheresis Science · doi:10.1016/s1473-0502(03)00164-2 · Cited by 61
Antagonist-Induced Intracellular Sequestration of Rabbit Bradykinin B2Receptor
Houle, S., Larrivée, J., Bachvarova, M., Bouthillier, J., Bachvarov, D. R., & Marceau, F. (2000) · Hypertension · doi:10.1161/01.hyp.35.6.1319 · Cited by 61
Self-citation
Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins.
Drapeau, G., deBlois, D., & Marceau, F. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20348-2 · Cited by 60
Self-citation
Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ace and aminopeptidase P
Blais, C., Marc–Aurèle, J., Simmons, W. H., Loute, G., Thibault, P., Skidgel, R. A., & Adam, A. (1999) · Peptides · doi:10.1016/s0196-9781(99)00020-0 · Cited by 60
Self-citation
Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions
Schmaier, A. H. (2000) · Current Opinion in Hematology · doi:10.1097/00062752-200009000-00001 · Cited by 60
Bradykinin B 1 receptor expression and function on T lymphocytes in active multiple sclerosis
Prat, A., Weinrib, L., Becher, B., Poirier, J., Duquette, P., Couture, R., & Antel, J. P. (1999) · Neurology · doi:10.1212/wnl.53.9.2087 · Cited by 60
Interleukin-1β Induces Bradykinin B2 Receptor Gene Expression through a Prostanoid Cyclic AMP-Dependent Pathway in Human Bronchial Smooth Muscle Cells
Schmidlin, F., Scherrer, D., Daeffler, L., Bertrand, C., Landry, Y., & Gies, J. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13270-1 · Cited by 60
Interleukin-1beta induces bradykinin B2 receptor gene expression through a prostanoid cyclic AMP-dependent pathway in human bronchial smooth muscle cells.
Schmidlin, F., Scherrer, D., Daeffler, L., et al. (1998) · PubMed · Cited by 59
The Plasma and Tissue Kininogen-kallikrein-kinin System: Role in the Cardiovascular System
Marcondes, S., & Antunes, E. (2005) · Current Medicinal Chemistry - Cardiovascular & Hematological Agents · doi:10.2174/1568016052773351 · Cited by 59
Bradykinin formation
Kaplan, A. P., Joseph, K., Shibayama, Y., Nakazawa, Y., Ghebrehiwet, B., Reddigari, S. R., & Silverberg, M. B. (1998) · Clinical Reviews in Allergy & Immunology · doi:10.1007/bf02737659 · Cited by 58
The pathogenesis of hereditary angioedema
Davis, A. E. (2003) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2003.08.012 · Cited by 56
Three Candidate Genes and Angiotensin-Converting Enzyme Inhibitor–Related Cough
Zee, R. Y. L., Rao, V. S., Paster, R. Z., Sweet, C. S., & Lindpaintner, K. (1998) · Hypertension · doi:10.1161/01.hyp.31.4.925 · Cited by 54
Purification and Properties of Membrane-Bound Aminopeptidase P from Rat Lung
Orawski, A. T., & Simmons, W. H. (1995) · Biochemistry · doi:10.1021/bi00035a032 · Cited by 54

Research works printed but not linked: 5

1 Abelous J, Bardier E. Les substances hypotensives de l’urine humaine normale. CR Soc Biol. 1909;66:511-512. (in French)
209 Rosenkrans B, Russmann S, Reichen J, Brunner-Ferber F, Bork K, Knolle J. Clinical proof-of-concept fort he bradykinin B2 antagonist; icatibant in liver cirrhosis and hereditary angioedema. Peptide Receptors Montreal 2004 Symposium. Montreal, Canada, 2004.
222 Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-153. · DOI · Paper page
241 Dumoulin MJ, Lamontagne D, Burnett J, Heublein D, Yamaguchi N, Adam A. Respective role of endogenous kinins and natriuretic peptides in the cardioprotective effect of omapatrilat following total heart ischemia (abstract). Eur Heart J. 2001;22:50.
250 Duan Q, Nikpoor B, Molinaro G, Meijer I, Rochefort D, Saint-Onge J, et al. Variants in XPNPEP2 increase susceptibility to ACE-inhibitor associated adverse reactions. Am J Hum Genet. In press 2005.

Sorted by citations

Acute Kidney Injury Associated with Cardiac Surgery
Rosner, M. H., & Okusa, M. D. (2005) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00240605 · Cited by 1,064
A catalog of genetic loci associated with kidney function from analyses of a million individuals
Study, L. C., Wuttke, M., Program, V. A. M. V., Li, Y., Li, M., Sieber, K. B., Feitosa, M. F., Gorski, M., Tin, A., Wang, L., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0407-x · Cited by 842
Distribution of 15 Human Kallikreins in Tissues and Biological Fluids
Shaw, J. L. V., & Diamandis, E. P. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.088104 · Cited by 390
A Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting Enzyme
Bernstein, K. E., Ong, F. S.-C., Blackwell, W.-L. B., Shah, K. H., Giani, J. F., González-Villalobos, R. A., Shen, X. Z., & Fuchs, S. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006809 · Cited by 330
Sensory and Signaling Mechanisms of Bradykinin, Eicosanoids, Platelet-Activating Factor, and Nitric Oxide in Peripheral Nociceptors
Pethö, G., & Reeh, P. W. (2012) · Physiological Reviews · doi:10.1152/physrev.00048.2010 · Cited by 299

See all 469

Authors: Moreau, M. E., Garbacki, N., Molinaro, G., Brown, N. J., Marceau, F., & Adam, A.
Affiliations: Université de Montréal (CA)
University of Liège (BE)
Vanderbilt University (US)
Centre hospitalier universitaire de Québec (CA)
ORCID: Garbacki, Nancy
Brown, Nancy J.
Marceau, François
Adam, Albert
Venue: Journal of Pharmacological Sciences
Publisher: Japanese Pharmacological Society
Published: 2005
Volume: 99
Issue: 1
Pages: 6-38
ISSN: 1347-8613 (ISSN-L)
1347-8648
DOI: 10.1254/jphs.srj05001x
OpenAlex: W1967632907
Semantic Scholar: 11ef9af17a7b09227baf4d743022d17406b6c59a
Cited by: 457
References: 324
Citations by year: 2026: 2 · 2025: 9 · 2024: 19 · 2023: 14 · 2022: 7 · 2021: 20 · 2020: 24 · 2019: 9 · 2018: 20 · 2017: 13 · 2016: 29 · 2015: 23 · 2014: 24 · 2013: 37 · 2012: 33
FWCI: 4.07
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Pharmacological Sciences (publishedVersion)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
ORBi (University of Liège) (submittedVersion, other-oa)
Funders: National Institutes of Health
National Heart, Lung, and Blood Institute (R01HL079184)
Topics: Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pineapple and bromelain studies
Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
Keywords: kallikrein-kinin system, bradykinin, kininogen, tissue kallikrein, plasma kallikrein, kinin receptors, metalloproteinases, antiproteases, serpins, pro-inflammatory effects, cardioprotection, renin-angiotensin system, coagulation, complement system, therapeutic target
MeSH terms: Angioedema, Angiotensin-Converting Enzyme Inhibitors, Animals, Bradykinin, Cardiovascular Diseases, Complement C1 Inactivator Proteins, Humans, Inflammation, Kallikreins, Aprotinin, Kidney Diseases, Peptidyl-Dipeptidase A, Kinins, Polymorphism, Genetic, Pyridines, Thiazepines, Neprilysin, Serpins, Randomized Controlled Trials as Topic, Kallikrein-Kinin System, Receptor, Bradykinin B2, Receptor, Bradykinin B1, Complement C1 Inhibitor Protein, Bradykinin B2 Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Kallikrein-Kinin System: Current and Future Pharmacological Targets

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks